莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LXRX 莱斯康制药

盘前交易 11-19 05:22:53 EST

0.9050

-0.0702

-7.20%

最高1.00	最低0.9050	成交量290.32万
今开0.9899	昨收0.9752	日振幅9.74%
总市值3.27亿	流通市值1.65亿	总股本3.61亿
成交额271.52万	换手率1.59%	流通股本1.82亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"莱斯康制药","latestPrice":0.905,"timestamp":1731963600000,"preClose":0.9752,"halted":0,"volume":2903158,"delay":0,"floatShares":182142700,"shares":361492295,"eps":-0.743931,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0702,"latestTime":"11-19 05:22:53 EST","open":0.9899,"high":1,"low":0.905,"amount":2715156.83290974,"amplitude":0.097416,"askPrice":1.03,"askSize":2500,"bidPrice":0.905,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.743931,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732026600000},"adr":0,"listingDate":955080000000,"adjPreClose":0.905,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.9101,"preClose":0.905,"latestTime":"19:54 EST","volume":83040,"amount":75544.1416,"timestamp":1731977672693},"volumeRatio":0.8535150686676632,"impliedVol":3.1112,"impliedVolPercentile":0.9761},"requestUrl":"/m/hq/s/LXRX/wiki","defaultTab":"wiki","newsList":[{"id":"2484677719","title":"莱斯康制药2024财年第三财季实现净利润-64.81百万美元，同比减少28.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677719?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945634,"startTime":"0","endTime":"0","summary":"11月19日，莱斯康制药公布财报，公告显示公司2024财年第三财季净利润为-64.81百万美元，同比减少28.26%；其中营业收入为1.75百万美元，同比增加980.25%，每股基本收益为-0.18美元。从资产负债表来看，莱斯康制药总负债1.43亿美元，其中短期债务1.30百万美元，资产负债比为2.25，流动比率为0.08。机构评级：截至2024年11月19日，当前有4家机构对莱斯康制药目标价做出预测，其中目标均价为5.35美元，其中最低目标价为1.40美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000053a243527d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000053a243527d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX"],"gpt_icon":0},{"id":"2484777166","title":"莱斯康制药盘中异动 早盘大幅下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484777166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484777166?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:41","pubTimestamp":1731944499,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时41分，莱斯康制药股票出现波动，股价快速下挫5.15%。截至发稿，该股报0.925美元/股，成交量94.439万股，换手率0.26%，振幅7.18%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为673.28%、559.02%、430.34%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为217.24%、75.18%、73.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118234139971a7391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118234139971a7391&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2483377313","title":"莱斯康制药盘中异动 股价大跌5.38%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377313?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:36","pubTimestamp":1731681401,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时36分，莱斯康制药股票出现异动，股价急速下挫5.38%。截至发稿，该股报1.00美元/股，成交量42.9173万股，换手率0.12%，振幅6.60%。莱斯康制药股票所在的生物技术行业中，整体跌幅为1.41%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2848.06%、192.08%、132.96%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.，振幅分别为114.92%、106.76%、61.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223641a23b5e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223641a23b5e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2483880358","title":"莱斯康制药盘中异动 早盘股价大跌5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483880358?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:07","pubTimestamp":1731510444,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时07分，莱斯康制药股票出现异动，股价急速下跌5.04%。截至发稿，该股报1.13美元/股，成交量64.826万股，换手率0.18%，振幅3.78%。最近的财报数据显示，该股实现营业收入1.65百万美元，净利润-53.43百万美元，每股收益-0.17美元，毛利1.34百万美元，市盈率-1.47倍。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230724971a64ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230724971a64ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2483062166","title":"辞海制药公司公布季度财报 - 财报摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483062166","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483062166?lang=zh_cn&edition=full","pubTime":"2024-11-13 07:27","pubTimestamp":1731454036,"startTime":"0","endTime":"0","summary":"   * Lexicon Pharmaceuticals Inc   报告本季度调整后每股亏损18美分，高于去年同期的每股-21美分。六位分析师对该季度的平均预期是每股亏损 16 美分。华尔街预期为每股亏损-18 美分至-15 美分。* Lexicon Pharmaceuticals Inc 公布的本季度每股收益为亏损 18 美分。* 该公司当季亏损 6481 万美元。* Lexicon Pharmaceuticals Inc 本季度股价下跌了 19.1%，今年迄今为止下跌了 17.0%。华尔街对 Lexicon Pharmaceuticals Inc 的 12 个月目标价中位数为 5.00  本摘要由 LSEG 11 月 12 日 11:26 p.m. UTC 调制解调器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"辞海制药公司公布季度财报 - 财报摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":0},{"id":"2482089782","title":"莱斯康制药盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482089782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482089782?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:49","pubTimestamp":1731422956,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时49分，莱斯康制药股票出现异动，股价快速下跌5.12%。截至发稿，该股报1.21美元/股，成交量17.8043万股，换手率0.05%，振幅3.15%。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Geovax Labs, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为139.62%、135.20%、62.13%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Heron Therapeutics, Inc.，振幅分别为49.39%、34.55%、26.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224916abba5703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224916abba5703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2482469168","title":"Lexicon Pharmaceuticals Inc 预计每股亏损16美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482469168","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482469168?lang=zh_cn&edition=full","pubTime":"2024-11-09 08:26","pubTimestamp":1731111969,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Inc 预计每股亏损16美分 - 财报前瞻莱克西康制药公司LXRX.OQLXRX.O将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。LSEG 分析师对 Lexicon Pharmaceuticals Inc 的平均预期是每股亏损 16 美分。华尔街对 Lexicon Pharmaceuticals Inc 的 12 个月目标价中位数为 5.00 美元，高于上一次收盘价 1.27 美元。11月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241109:nL4T3MG018:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":0},{"id":"2482899254","title":"莱斯康制药盘中异动 急速下挫5.00%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482899254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482899254?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:09","pubTimestamp":1731082173,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日00时09分，莱斯康制药股票出现异动，股价大幅下跌5.00%。截至发稿，该股报1.24美元/股，成交量71.109万股，换手率0.20%，振幅6.15%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Lipella Pharmaceuticals Inc.、Matinas Biopharma Holdings, Inc.较为活跃，换手率分别为633.93%、52.35%、51.95%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为95.56%、87.00%、52.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000934971a56aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000934971a56aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2481703187","title":"莱斯康制药盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481703187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481703187?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:47","pubTimestamp":1730994479,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时47分，莱斯康制药股票出现波动，股价大幅上涨5.37%。截至发稿，该股报1.28美元/股，成交量84.3871万股，换手率0.23%，振幅7.44%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Celularity Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为750.60%、159.08%、95.37%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234759a221144a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234759a221144a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2481001999","title":"新仿制药需求旺盛，安乃近制造商 Viatris 季度业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2481001999","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481001999?lang=zh_cn&edition=full","pubTime":"2024-11-07 21:52","pubTimestamp":1730987529,"startTime":"0","endTime":"0","summary":"新仿制药需求旺盛，安乃近制造商 Viatris 季度业绩超出预期路透11月7日 - 制药商维特瑞VTRS.O周四公布的第三季度利润和营收超出华尔街预期，这主要得益于其哮喘和多动症等新仿制药的强劲需求，该公司股价盘前上涨了2.5%。Viatris 于 6 月份完成了对妇女健康和活性药物成分   业务的剥离。不过，Viatris 将 2024 年的利润预期从之前的每股 2.58 美元至 2.73 美元下调至 2.56 美元至 2.71 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4T3ME1N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0957799991.USD","LU1894683348.USD","LU1066053197.SGD","BK4533","IE00B2B36J28.USD","LU0784385840.USD","LU1894683264.USD","LXRX","LU0058720904.USD","LU0225771236.USD","BK4585","AZN.UK","LU0077335932.USD","LU0792757196.USD","LU1839511570.USD","LU0203345920.USD","SG9999003800.SGD","BK4588","LU0882574055.USD","LU0047473722.EUR","LU0868494617.USD","LU0963555726.SGD","BK4534","LU0985481810.HKD","03165","VTRS","LU0976567544.SGD","BK5011","LU0997586432.USD","LU0114720955.EUR","PFE","LU0203347892.USD","LU0456855351.SGD","LU0889565080.SGD","LU0949170426.SGD","IE00BLSP4239.USD","LU0170899867.USD","IE0002141913.USD","BK4581","LU0310799852.SGD","LU0553294199.USD","LU0225284248.USD","LU0211327993.USD","LU0823416689.USD","LU0661504455.SGD","SG9999002224.SGD","SG9999002232.USD","BK4568","SG9999001176.USD","LU0011850046.USD"],"gpt_icon":1},{"id":"2480580527","title":"Lexicon Pharmaceuticals Inc   预计每股亏损16美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580527","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580527?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:38","pubTimestamp":1730734705,"startTime":"0","endTime":"0","summary":"   * 莱克西康制药公司   预计在11月6日公布截至2024年9月30日的业绩报告时，季度收入将有所增长(预计)。* LSEG 分析师对 Lexicon Pharmaceuticals Inc 的平均预期是每股亏损 16 美分。* 华尔街对 Lexicon Pharmaceuticals Inc 的 12 个月目标价中位数为 5.00 美元，高于上一次收盘价 1.22 美元。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lexicon Pharmaceuticals Inc   预计每股亏损16美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"gpt_icon":0},{"id":"2480889951","title":"莱斯康制药股价重挫36.67% 市值跌1.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889951?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467949,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分，莱斯康制药股票出现波动，股价急速下挫36.67%。截至发稿，该股报1.24美元/股，成交量299.249万股，换手率0.83%，振幅4.61%。最近的财报数据显示，该股实现营业收入1.65百万美元，净利润-53.43百万美元，每股收益-0.17美元，毛利1.34百万美元，市盈率-1.58倍。机构评级方面，在所有6家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121322995bdab07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121322995bdab07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2480885426","title":"BUZZ--美国股票走势-Wayfair, B. Riley, Church & Dwight","url":"https://stock-news.laohu8.com/highlight/detail?id=2480885426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480885426?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:24","pubTimestamp":1730467473,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      11月1日 - 受亚马逊强劲业绩抵消上一交易日科技股大跌的影响，周五美股期货上涨，投资者等待非农就业数据，以了解美联储关键政策利率轨迹。美东时间9:13，道指电子盘  上涨0.52%，报42,165点。标普500指数小型股  上涨0.42%，报5762.5点；纳斯达克100指数小型股  上涨0.39%，报20099点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOM","LU0081259029.USD","LU1691799644.USD","WMPN","LU1074936037.SGD","CAH","HK0000306685.HKD","IE000ITXATA3.USD","IE00B19Z9505.USD","IR","LU1066053197.SGD","IE00B1XK9C88.USD","BK4533","IE000YTNTUN2.SGD","CHD","IE00B1BXHZ80.USD","W","IE00B2B36J28.USD","IE00BWXC8680.SGD","BK4571","IE0002141913.USD","BK4187","BK4585","PDEX","IE00B7KXQ091.USD","LU0630314457.HKD","LXRX","SIRI","AMZN","HALO","LU0321505439.SGD","LU0878866978.SGD","LU1732800096.USD","LU0234572021.USD","CVX","IE00BN8TJ469.HKD","ABT","IE00B19Z8X17.USD","LU0070302665.USD","BK4581","AAPL","RILY","SG9999004303.SGD","LU0868494617.USD","BK4535","HII","IE0031619046.USD","IE00BJTD4V19.USD","BK4211"],"gpt_icon":1},{"id":"2480400721","title":"BUZZ-Lexicon 因 FDA 顾问投票反对 1 型糖尿病附加药物而下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2480400721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480400721?lang=zh_cn&edition=full","pubTime":"2024-11-01 20:25","pubTimestamp":1730463953,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    11月1日 - ** 药物开发商莱克西康制药公司  股价盘前下跌约35.9%，至1.25美元** 周四晚些时候，美国食品和药物管理局（FDA）顾问投票反对 (link) 推荐 Lexicon 的胰岛素治疗附加疗法用于控制 1 型糖尿病和慢性肾病成人患者的血糖水平。** 专家小组以11:3的票数否决了索他利氟嗪（sotagliflozin）这种药物。** 专家小组成员表示，他们对 缺乏临床数据感到 \"失望\"，因为可能受益最大的亚组患者没有得到前瞻性研究。** 截至上一交易日收盘，股价累计上涨 27.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2480062596","title":"FDA 顾问投票反对莱克西康制药公司的 1 型糖尿病附加药","url":"https://stock-news.laohu8.com/highlight/detail?id=2480062596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480062596?lang=zh_cn&edition=full","pubTime":"2024-11-01 04:47","pubTimestamp":1730407660,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透10月31日 - 美国食品和药物管理局的独立顾问周四投票反对推荐Lexicon Pharmaceuticals公司的  作为胰岛素疗法的附加疗法，用于控制1型糖尿病和慢性肾病成人患者的血糖水平。专家组以13票对3票反对推荐这种化学名称为索他利氟嗪（sotagliflozin）的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2479235119","title":"莱斯康制药盘中异动 急速上涨5.11%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479235119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479235119?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:19","pubTimestamp":1730218752,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时19分，莱斯康制药股票出现波动，股价大幅上涨5.11%。截至发稿，该股报1.96美元/股，成交量160.882万股，换手率0.45%，振幅5.91%。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1314.96%、1093.36%、315.12%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为183.65%、88.24%、65.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030001913971a2faa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030001913971a2faa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2478648160","title":"莱斯康制药盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648160?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:53","pubTimestamp":1730123616,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时53分，莱斯康制药股票出现波动，股价急速拉升5.00%。截至发稿，该股报1.89美元/股，成交量43.7535万股，换手率0.12%，振幅4.48%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为578.10%、51.01%、39.52%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、45.41%、29.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215336a1f25955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215336a1f25955&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2477355163","title":"莱斯康制药盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477355163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477355163?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:12","pubTimestamp":1729703525,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时12分，莱斯康制药股票出现异动，股价急速跳水5.10%。截至发稿，该股报1.84美元/股，成交量199.919万股，换手率0.55%，振幅9.02%。莱斯康制药股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1847.55%、1497.50%、496.80%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.，振幅分别为109.26%、71.86%、68.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401120598e3e0c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401120598e3e0c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2477786258","title":"莱斯康制药盘中异动 急速下挫5.05%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477786258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477786258?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:06","pubTimestamp":1729523175,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时06分，莱斯康制药股票出现异动，股价大幅下跌5.05%。截至发稿，该股报1.98美元/股，成交量121.528万股，换手率0.34%，振幅4.57%。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5516.42%、2949.03%、1231.17%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、131.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021230616971a167f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021230616971a167f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2476323099","title":"莱斯康制药盘中异动 股价大涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476323099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476323099?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:31","pubTimestamp":1729258291,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时31分，莱斯康制药股票出现异动，股价快速拉升5.72%。截至发稿，该股报2.13美元/股，成交量19.0573万股，换手率0.05%，振幅3.73%。机构评级方面，在所有6家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018213131a1e1bdc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018213131a1e1bdc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexpharma.com","stockEarnings":[{"period":"1week","weight":-0.2874},{"period":"1month","weight":-0.5649},{"period":"3month","weight":-0.4613},{"period":"6month","weight":-0.4581},{"period":"1year","weight":-0.192},{"period":"ytd","weight":-0.4085}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。通过基因敲除技术和先进的医疗技术综合平台，该公司已经系统研究了小白鼠体内近5000个基因的生理和行为功能，且评估了由相应的人类基因作为潜在药物靶标所编码的蛋白质的效用，并且已经在活体（或活的有机体）内确定并验证了100多个能很好地应用于药物发现的靶标。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.042931},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.058519},{"month":3,"riseRate":0.5,"avgChangeRate":-0.006016},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.011119},{"month":5,"riseRate":0.52,"avgChangeRate":0.035958},{"month":6,"riseRate":0.64,"avgChangeRate":0.119795},{"month":7,"riseRate":0.48,"avgChangeRate":0.017089},{"month":8,"riseRate":0.24,"avgChangeRate":-0.027412},{"month":9,"riseRate":0.32,"avgChangeRate":0.002483},{"month":10,"riseRate":0.52,"avgChangeRate":-0.007629},{"month":11,"riseRate":0.36,"avgChangeRate":-0.042862},{"month":12,"riseRate":0.5,"avgChangeRate":0.078876}],"exchange":"NASDAQ","name":"莱斯康制药","nameEN":"Lexicon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱斯康制药,LXRX,莱斯康制药股票,莱斯康制药股票老虎,莱斯康制药股票老虎国际,莱斯康制药行情,莱斯康制药股票行情,莱斯康制药股价,莱斯康制药股市,莱斯康制药股票价格,莱斯康制药股票交易,莱斯康制药股票购买,莱斯康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}